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OBJECTIVE: Our study aimed at (1) evaluating neonatal treatment and outcome
of neonates with either a prenatal or a postnatal diagnosis of esophageal atresia
(EA) and (2) analyzing the impact of prenatal diagnosis on outcome based on the
type of EA.
STUDY DESIGN: We conducted a population-based study using data from the
French National Register for infants with EA born from 2008-2010. We compared
prenatal, maternal, and neonatal characteristics among children with prenatal vs
postnatal diagnosis and EA types I and III. We defined a composite variable of
morbidity (anastomotic esophageal leaks, recurrent fistula, stenosis) and death at
1 year.
RESULTS: Four hundred sixty-nine live births with EA were recorded with a
prenatal diagnosis rate of 24.3%; 82.2% of EA type I were diagnosed prenatally
compared with 17.9% of EA type III (P < .001). Transfer after birth was lower in
case of prenatal diagnosis (25.6% vs 82.5%; P < .001). The delay between birth
and first intervention did not differ significantly among groups. The defect size
was longer among the prenatal diagnosis group (2.61 vs 1.48 cm; P < .001). The
composite variables were higher in prenatal diagnosis subset (44% vs 27.6%; P =
.003) and in EA type I than in type III (58.1% vs 28.3%; P < .001).
CONCLUSION: Despite the excellent survival rate of EA, cases with antenatal
detection have a higher morbidity rate related to the EA type (type I and/or long
gap). Even though it does not modify neonatal treatment and the 1-year outcome,
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